Literature DB >> 7542470

Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus.

A E Brewster1, S E Davidson, W P Makin, R Stout, P A Burt.   

Abstract

A total of 197 patients, who presented to the Christie Hospital with advanced carcinoma of the oesophagus, were treated with the high dose rate microSelectron between June 1988 and June 1992. In 54%, a single intraluminal brachytherapy treatment resulted in useful palliation, which was sustained for a substantial part of the patient's remaining life. The simplicity of the treatment, which could be completed as a day case procedure and did not cause significant morbidity, commends itself in the palliation of these patients who have poor overall survival and quality of life. Approaches that might improve the response rate in those patients who did not gain significant palliation after a single treatment are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7542470     DOI: 10.1016/s0936-6555(05)80810-6

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.

Authors:  B G Taal; B M Aleman; C C Koning; H Boot
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

2.  Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.

Authors:  S Polinder; M Y V Homs; P D Siersema; E W Steyerberg
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

3.  Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer.

Authors:  Wojciech Burchardt; Artur Chyrek; Ewa Burchardt; Grzegorz Bielęda; Maciej Trojanowski; Adam Chicheł
Journal:  J Contemp Brachytherapy       Date:  2019-12-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.